By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Two Blades Foundation has granted Syngenta access to its genome engineering technology for commercial uses in certain crop plants under an agreement announced late on Tuesday.

The non-exclusive license provides Syngenta access to the Transcription Activator Like (TAL) effector Code, a technology for engineering proteins that bind to specific DNA sequences for precise modulation of genomes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.